<DOC>
	<DOCNO>NCT03092648</DOCNO>
	<brief_summary>Chronic Obstructive Pulmonary Disease ( COPD ) kind chronic bronchitis emphysema characteristic long-term poor airflow , result chronic pulmonary heart disease , chronic respiratory failure even death . Anatomically , pulmonary bronchus structure COPD patient damage repaired recent clinical treatment far . This study intend carry open , single-armed , phase I/II clinical trial investigate whether bronchial basal cell regenerate damage lung tissue . During treatment , bronchial basal cell isolated patient ' bronchus expand vitro . After careful characterization , culture cell transplant autologously lesion fiberoptic bronchoscopy . The safety efficacy treatment monitor measure key clinical indicator .</brief_summary>
	<brief_title>Autologous Bronchial Basal Cells Transplantation Treatment Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Aged 40 75 ; Diagnosed COPD accord guideline ( a. symptom productive cough , sputum production shortness breath ; b. poor airflow indicate FEV1 &lt; 70 % predict value FEV1/FVC &lt; 0.7 pulmonary function test ; c. exclusion pulmonary disease CT blood examination . ) ; Clinically stable 4 week ; Tolerant bronchofiberscope ; Written inform consent sign . Pregnant lactating woman ; Patients positive syphilis , HIV ; Patients malignant tumor ; Patients serious significant pulmonary infection need antiinfection treatment ; Patients serious heart disease ( NYHA class ⅢⅣ ) ; Patients history abuse alcohol illicit drug ; Patients participate clinical trial past 3 month ; Patients assess inappropriate participate clinical trial investigator .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>